Invesco EQQQ NASDAQ-100 UCITS ETF USD is a equity ETF from Invesco tracking the EQQQ NASDAQ-100 index through physical replication. Domiciled in Ireland and launched in 2002, the fund manages about 11.4 bn € and charges a TER of 0.30% — 30 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
Invesco EQQQ NASDAQ-100 UCITS ETF USD competes with 3 other products on the same index (EQQQ NASDAQ-100): it ranks 1st by fund size and 1st by ongoing cost, with a TER of 0.30% against a group median of 0.32%. It has been listed since 2002, 24 years of track record — the oldest in its comparison group.
On a €10,000 investment the TER costs 30 € a year, and no product in the group costs less.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 44.9% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in USD. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| NVIDIA Corporation | 7.6% |
| Apple Inc. | 6.7% |
| Micron Technology Inc | 5.6% |
| Microsoft Corporation | 4.3% |
| Advanced Micro Devices Inc | 4.1% |
| Amazon.com Inc | 4.0% |
| Tesla Inc | 3.3% |
| Alphabet Inc Class A | 3.3% |
| Intel Corporation | 3.0% |
| Alphabet Inc Class C | 3.0% |
| Borsa Italiana | EQQQ | EUR |
| XETRA | EQQQ | EUR |
| Francoforte | EQQQ | EUR |
| London Stock Exchange | EQQQ | GBX |
| London Stock Exchange | EQQU | USD |
| Euronext Paris | EQQQ | EUR |
| SIX Swiss Exchange | EQQQ | USD |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.